» Articles » PMID: 37435719

National Initiatives on Salt Substitutes: Scoping Review

Overview
Publisher JMIR Publications
Date 2023 Jul 12
PMID 37435719
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Salt substitutes are edible salts that contain less sodium chloride owing to its partial substitution with other minerals, which serve as an important and effective intervention and public health strategy targeting hypertension and its secondary diseases, despite a small degree of controversy.

Objective: This study aimed to identify the current salt substitute initiatives in various nations and intergovernmental organizations (IGOs) worldwide and summarize their types and characteristics.

Methods: A scoping review was performed based on Arksey and O'Malley's framework and the latest guidance from the Joanna Briggs Institute. Searches were conducted on Google; government websites on food, health, and other related topics; PubMed; Web of Science; and Google Scholar from January 2022 to May 2022. Initiatives related to salt substitutes that were included in the study focused on the involvement of governments or IGOs through the publication of standards, actions, collaborations, funding, and so on. Data were extracted into Microsoft Excel (version 2019; Microsoft Corp) based on predefined items and analyzed using narrative synthesis and frequency count methods.

Results: A total of 35 initiatives from 11 countries (of which 9 are high-income countries) and 3 IGOs were identified. We classified all salt substitute initiatives into 5 types, namely benefit-risk assessments and cautions; plans and actions; regulations and standards; labels; and food reformulation, cooperation with the food industry, and media. More than half (18/35, 51%) of the salt substitute initiatives were launched within the past 5 years. Except for regulations and standards, salt substitute initiatives are, in general, part of the salt reduction framework. No nation or IGO has yet reported on the monitoring and implications of the use of salt substitutes.

Conclusions: Despite the limited number of salt substitute initiatives worldwide at present, a review on the different types and characteristics of such initiatives could be helpful in providing a reference for policy makers and stakeholders. Given the great potential of salt substitutes in improving hypertension and stroke, we call on more nations to pay attention to these substitutes and propose salt substitute initiatives in line with their national conditions.

Citing Articles

Persistent effect of salt reduction in schoolchildren and their families: 1-year follow-up after an application-based cluster randomized controlled trial.

Li Y, Zhang P, He F, Luo R, Song J, Wang C BMC Med. 2025; 23(1):41.

PMID: 39865267 PMC: 11771009. DOI: 10.1186/s12916-025-03868-8.


Long-Term Effects of a Comprehensive Intervention Strategy for Salt Reduction in China: Scale-Up of a Cluster Randomized Controlled Trial.

Liu M, Xu J, Li Y, He F, Zhang P, Song J Nutrients. 2024; 16(23.

PMID: 39683487 PMC: 11643943. DOI: 10.3390/nu16234092.


Health Claims, Product Features and Instructions for Use on the Labels of Potassium-enriched Salt Products: A Content Analysis.

Bullen J, Yin X, Kissock K, Fisher L, Neal B, Trieu K Curr Dev Nutr. 2024; 8(11):104473.

PMID: 39524215 PMC: 11547896. DOI: 10.1016/j.cdnut.2024.104473.


Salt substitute recommendations for heart failure patients may influence guideline-directed medical therapies titration.

Tartiere J, Roubille F, Salvat M, Damy T, Beauvais F, Berthelot E ESC Heart Fail. 2024; 11(4):2455-2459.

PMID: 38783593 PMC: 11287297. DOI: 10.1002/ehf2.14706.

References
1.
Arnold M, Harding M, Conley A . Dietary Guidelines for Americans 2020-2025: Recommendations from the U.S. Departments of Agriculture and Health and Human Services. Am Fam Physician. 2021; 104(5):533-536. View

2.
Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W . Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019; 394(10204):1145-1158. PMC: 6891889. DOI: 10.1016/S0140-6736(19)30427-1. View

3.
Ayach T, Nappo R, Paugh-Miller J, Ross E . Life-threatening hyperkalemia in a patient with normal renal function. Clin Kidney J. 2015; 7(1):49-52. PMC: 4389164. DOI: 10.1093/ckj/sft151. View

4.
Tricco A, Lillie E, Zarin W, OBrien K, Colquhoun H, Levac D . PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018; 169(7):467-473. DOI: 10.7326/M18-0850. View

5.
Adrogue H, Madias N . Sodium and potassium in the pathogenesis of hypertension. N Engl J Med. 2007; 356(19):1966-78. DOI: 10.1056/NEJMra064486. View